Details van artikel 268 van 426 gevonden artikelen
138 Phase 1 dose-escalation study of STRO-002, an anti-folate receptor alpha (FRα) antibody drug conjugate (ADC), in patients with advanced platinum-resistant/refractory epithelial ovarian cancer (OC)
Titel:
138 Phase 1 dose-escalation study of STRO-002, an anti-folate receptor alpha (FRα) antibody drug conjugate (ADC), in patients with advanced platinum-resistant/refractory epithelial ovarian cancer (OC)
Auteur:
Naumann, R. Braiteh, F. Diaz, J. Hamilton, E. Diab, S. Schilder, R. Moroney, J. Martin, L. Uyar, D. O’Malley, D. Penson, R. DiLea, C. Palumbo, M. DeAlmeida, V. Berman, C. Matheny, S. Molina, A.
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 30 () nr. S3 pagina's A61
Jaar:
2020
Inhoud:
Uitgever:
Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 268 van 426 gevonden artikelen